Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae
- PMID: 12529019
- DOI: 10.1034/j.1600-0463.2002.1100909.x
Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae
Abstract
Mutations in the genes for the subunits GyrA and ParC of the target enzymes DNA gyrase and topoisomerase IV are important mechanisms of resistance in quinolone-resistant bacteria, including Neisseria gonorrhoeae. The target enzymes also consist of the subunits GyrB and ParE, respectively, though their role in quinolone-resistance has not been fully investigated. We sequenced the quinolone-resistance-determining regions (QRDR) of gyrA, gyrB, parC, and parE in 25 ciprofloxacin-resistant strains from Bangladesh (MIC 4-->32 mg/l) and 5 susceptible strains of N. gonorrhoeae. All the resistant strains had three or four mutations. Two of these were at positions 91 and 95 of gyrA. Fourteen strains had an additional mutation in parC at position 91, and 17 strains had an additional mutation in parE in position 439. No alterations were found in gyrB. The five susceptible strains had identical DNA sequences. Data indicate that the mutations detected in the QRDR of gyrA and parC may be important in the development of quinolone resistance. According to transformation experiments we assume that the alteration in parE is not related to a high degree of quinolone resistance. There was no correlation between ciprofloxacin MICs and pattern or number of mutations in the target genes.
Similar articles
-
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.Antimicrob Agents Chemother. 2001 Mar;45(3):734-8. doi: 10.1128/AAC.45.3.734-738.2001. Antimicrob Agents Chemother. 2001. PMID: 11181352 Free PMC article.
-
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.J Urol. 2000 Sep;164(3 Pt 1):847-51. doi: 10.1097/00005392-200009010-00060. J Urol. 2000. PMID: 10953166
-
Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.Sex Transm Dis. 2004 Mar;31(3):180-4. doi: 10.1097/01.olq.0000114654.91972.66. Sex Transm Dis. 2004. PMID: 15076932
-
Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.Antimicrob Agents Chemother. 2001 Jan;45(1):117-23. doi: 10.1128/AAC.45.1.117-123.2001. Antimicrob Agents Chemother. 2001. PMID: 11120953 Free PMC article.
-
[Quinolone-resistant Neisseria gonorrhoeae: A new public health problem in Spain].Enferm Infecc Microbiol Clin. 2002 Mar;20(3):123-6. doi: 10.1016/s0213-005x(02)72762-6. Enferm Infecc Microbiol Clin. 2002. PMID: 11904085 Review. Spanish. No abstract available.
Cited by
-
Multidrug Resistance Profiles and Resistance Mechanisms to β-Lactams and Fluoroquinolones in Bacterial Isolates from Hospital Wastewater in Bangladesh.Curr Issues Mol Biol. 2023 Aug 5;45(8):6485-6502. doi: 10.3390/cimb45080409. Curr Issues Mol Biol. 2023. PMID: 37623228 Free PMC article.
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
-
Machine learning models for Neisseria gonorrhoeae antimicrobial susceptibility tests.Ann N Y Acad Sci. 2023 Feb;1520(1):74-88. doi: 10.1111/nyas.14549. Epub 2022 Dec 27. Ann N Y Acad Sci. 2023. PMID: 36573759 Free PMC article. Review.
-
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0041422. doi: 10.1128/aac.00414-22. Epub 2022 Aug 16. Antimicrob Agents Chemother. 2022. PMID: 35972242 Free PMC article.
-
Alternative Pathways to Ciprofloxacin Resistance in Neisseria gonorrhoeae: An In Vitro Study of the WHO-P and WHO-F Reference Strains.Antibiotics (Basel). 2022 Apr 8;11(4):499. doi: 10.3390/antibiotics11040499. Antibiotics (Basel). 2022. PMID: 35453249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
